ATE113962T1 - Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine. - Google Patents

Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine.

Info

Publication number
ATE113962T1
ATE113962T1 AT84903305T AT84903305T ATE113962T1 AT E113962 T1 ATE113962 T1 AT E113962T1 AT 84903305 T AT84903305 T AT 84903305T AT 84903305 T AT84903305 T AT 84903305T AT E113962 T1 ATE113962 T1 AT E113962T1
Authority
AT
Austria
Prior art keywords
polypeptide
monoclonal antibodies
antibodies against
induced monoclonal
oncoproteins
Prior art date
Application number
AT84903305T
Other languages
English (en)
Inventor
Henry L Niman
Richard Alan Lerner
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Application granted granted Critical
Publication of ATE113962T1 publication Critical patent/ATE113962T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Adhesives Or Adhesive Processes (AREA)
AT84903305T 1983-08-17 1984-08-17 Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine. ATE113962T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52408483A 1983-08-17 1983-08-17

Publications (1)

Publication Number Publication Date
ATE113962T1 true ATE113962T1 (de) 1994-11-15

Family

ID=24087698

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84903305T ATE113962T1 (de) 1983-08-17 1984-08-17 Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine.

Country Status (9)

Country Link
EP (2) EP0152477B1 (de)
JP (2) JPS61500068A (de)
AT (1) ATE113962T1 (de)
AU (2) AU580738B2 (de)
CA (1) CA1219232A (de)
DE (1) DE3486356T2 (de)
IT (1) IT1177968B (de)
WO (1) WO1985000807A1 (de)
ZA (1) ZA846439B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591587A (en) * 1983-08-17 1997-01-07 The Scripps Research Institute Polypeptide-induced monoclonal receptors to protein ligands
US5972629A (en) 1984-08-17 1999-10-26 The Scripps Research Institute Method for characterizing antigenic reactivity of biological sample
US4798787A (en) * 1984-09-19 1989-01-17 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
CA1296660C (en) * 1985-01-29 1992-03-03 Walter P. Carney Monoclonal antibody against a ras oncogene p21 related dodecapeptide
US5081230A (en) * 1987-07-08 1992-01-14 E. I. Dupont Denemours And Company Monoclonal antibodies reactive with normal and oncogenic forms of the ras p21 protein
US5443956A (en) * 1985-01-29 1995-08-22 Oncogene Science, Inc. Detection, quantitation and classification of RAS proteins in body fluids and tissues
US6200764B1 (en) 1985-01-29 2001-03-13 Bayer Corporation Detection, quantitation and classification of ras proteins in body fluids and tissues
US5028527A (en) * 1988-02-22 1991-07-02 Applied Bio Technology Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
US4898932A (en) * 1985-01-29 1990-02-06 E. I. Du Pont De Nemours And Company Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
EP0203587A3 (de) * 1985-05-30 1989-08-09 F. Hoffmann-La Roche Ag Ras-Oncogene-Peptide und Antikörper
EP0206065A3 (de) * 1985-06-27 1989-04-19 James R. Feramisco Verfahren zum Nachweis von oncogenischen und proto-oncogenischen Proteinen in extrazelligen biologischen Flüssigkeiten
US6083709A (en) * 1985-08-21 2000-07-04 Osi Pharmaceuticals, Inc. Immunoassay for detection of mutant P53 polypeptide in serum
DE3650676T2 (de) * 1985-08-28 1998-09-17 George Pieczenik Verfahren und mittel zur sortierung und bestimmung biologischer informationen
US5866363A (en) * 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
JP2726264B2 (ja) * 1986-05-06 1998-03-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｎ‐ｍｙｃタンパク質のためのアッセイ及び抗体
DK354487A (da) * 1986-07-11 1988-01-12 Noboru Yanaihara Oncogen-relaterede peptider
JPS6374492A (ja) * 1986-09-18 1988-04-04 Hiroshi Shiyuku モノクロ−ナル抗体
AU624789B2 (en) * 1987-02-19 1992-06-25 Amgen, Inc. Purified platelet-derived growth factor and methods for purification thereof
AU1874988A (en) * 1987-07-07 1989-03-09 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Hybridoma cell lines, monoclonal antibodies and their use for immunocytochemical detection or fluorescence-activated sorting of cells expressing the c-myb protein and pharmaceutical compositions
US5094941A (en) * 1987-12-31 1992-03-10 Zymogenetics, Inc. Monoclonal antibodies to PDGF
WO1989008710A1 (en) * 1988-03-08 1989-09-21 E.I. Du Pont De Nemours And Company Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
DE68929511T2 (de) * 1988-04-22 2004-11-18 Bayer Corp. Nachweis, Quantifizierung und Klassifizierung von RAS-Proteinen in Körperflüssigkeiten und Geweben
EP0354808B1 (de) * 1988-08-12 1997-12-03 Ligand Pharmaceuticals Incorporated Polypeptid-induzierte monoklonale Rezeptoren gegen Proteinliganden
WO1991011719A1 (en) * 1990-01-26 1991-08-08 Washington Research Foundation Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
GB9103974D0 (en) * 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002790A1 (fr) * 1980-03-18 1981-10-01 Ciba Geigy Ag Nouveau support solide pour proteines a des fins analytiques
EP0103893A3 (de) * 1982-09-22 1986-03-19 Daicel Chemical Industries, Ltd. Macrocyclische Diester
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
ZA84617B (en) * 1983-02-14 1984-09-26 Arup Sen Synthetic polypeptides from viryl oncogenes
US4599306A (en) * 1983-04-15 1986-07-08 Amgen Monoclonal antibodies which specifically bind to human immune interferon
NZ220200A (en) * 1986-05-19 1990-08-28 Viral Technologies Inc Hiv related peptides, antibodies to the peptides and vaccines therefrom
CA1339069C (en) * 1987-11-09 1997-07-29 Henry Lee Niman Polypeptide-induced monoclonal receptors to protein ligand
EP0317804B1 (de) * 1987-11-24 1995-10-04 Abbott Laboratories HIV-Peptide und Methoden für den Nachweis von HIV

Also Published As

Publication number Publication date
EP0152477A4 (de) 1987-04-16
DE3486356T2 (de) 1995-06-01
IT8448736A1 (it) 1986-02-17
JPS61500068A (ja) 1986-01-16
JPH07284398A (ja) 1995-10-31
EP0152477B1 (de) 1994-11-09
AU633253B2 (en) 1993-01-28
WO1985000807A1 (en) 1985-02-28
ZA846439B (en) 1985-03-27
EP0592026A1 (de) 1994-04-13
IT1177968B (it) 1987-09-03
EP0152477A1 (de) 1985-08-28
JP2592581B2 (ja) 1997-03-19
AU580738B2 (en) 1989-02-02
DE3486356D1 (de) 1994-12-15
AU3386089A (en) 1989-08-24
IT8448736A0 (it) 1984-08-17
AU3395084A (en) 1985-03-12
CA1219232A (en) 1987-03-17

Similar Documents

Publication Publication Date Title
ATE113962T1 (de) Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine.
ATE82072T1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
DE3381781D1 (de) Hochspezifisches antiserum gegen prokollagen-peptid col 1 (typ iii) und prokollagen-peptid (typ iii), seine herstellung und verwendung.
FI895505A0 (fi) Menetelmä ja reagenssipakkaus endotoksiinin tai endotoksiinin kaltaisen aineen määrittämiseksi näytteestä sekä menetelmässä käytettäväksi tarkoitetut monoklonaaliset vasta-aineet
FI860112A0 (fi) Menetelmä ja laite immunoanalyysejä varten
DE68924850D1 (de) Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
GB1488532A (en) Unitized solid phase immunoassay kit and method
ES8400199A1 (es) Procedimiento para la produccion de dispositivos de analisis inmunologicos.
DE59409947D1 (de) Verringerung des Hook-Effekts in Immuntests mit teilchenförmigem Trägermaterial
NO159820C (no) Fremgangsmaate ved bestemmelse av antigen-antistoff-reaksjoner.
DE3576854D1 (de) Immunchemisches messverfahren fuer haptene und proteine.
ATE123340T1 (de) Diagnostischer nachweis unter verwendung von chimären antikörpern.
NL181461C (nl) Werkwijze en reagenskit voor het bepalen van antigenen, antilichamen of antigeen-antilichaam-complexen of -conjugaten.
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
ATE138205T1 (de) Verfahren zum nachweis von phosphoryliertes tyrosin enthaltenden proteinen
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
ES511156A0 (es) Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
ATE145480T1 (de) Verfahren zur bestimmung eines analyten
DE58907087D1 (de) Verfahren zur Bestimmung von für ein Antigen klassenspezifischen Antikörpern und dazu geeignetes Reagenz.
Abelev et al. Performance of multistep immunochemical reactions by counterflow isotachophoresis on nitrocellulose membranes—I. Immunoblotting
ATE40475T1 (de) Verbesserter immunoassay zur bestimmung von antikoerpern gegen native-dna.
Glad et al. A new method for immunochemical quantification
DE59007046D1 (de) Verfahren zum Nachweis von Analyten.
ATE44980T1 (de) Immunologisches verfahren zum nachweis von brustkrebs durch verwendung von monoklonalen antikoerpern.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time